Literature DB >> 14698802

Living forever and dying in the attempt.

Leonard Hayflick1.   

Abstract

Since the first cell culture was set at the beginning of the twentieth century it was believed that all cultured cells, if provided with the proper conditions, would replicate indefinitely. Sixty years later we overthrew this dogma by finding that normal cells have a finite capacity to replicate and that only abnormal or cancer cell populations can replicate indefinitely. We interpreted these findings to bear on our understanding of the aging process. If, as had been previously thought, normal cells can replicate indefinitely, then age changes could not have an intracellular origin. Our findings demonstrated that, on the contrary, age changes do have an intracellular origin. The hundreds of changes that were subsequently found to precede the loss of replicative capacity have been interpreted to be age changes and the finitude of replication to be an expression of longevity determination. Subsequent findings by others have determined the molecular mechanism that governs the finitude of normal cell replicative capacity and how immortal cancer cells escape this inevitability. Thus, key events in our understanding of aging, longevity determination and cancer have been revealed.

Entities:  

Mesh:

Year:  2003        PMID: 14698802     DOI: 10.1016/j.exger.2003.09.003

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  19 in total

1.  Reversibility of replicative senescence in Saccharomyces cerevisiae: effect of homologous recombination and cell cycle checkpoints.

Authors:  Sandra C Becerra; Hiranthi T Thambugala; Alison Russell Erickson; Christopher K Lee; L Kevin Lewis
Journal:  DNA Repair (Amst)       Date:  2011-11-09

2.  Telomere attrition and accumulation of senescent cells in cultured human endothelial cells.

Authors:  R Hastings; M Qureshi; R Verma; P S Lacy; B Williams
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

3.  Who wants to live forever?

Authors:  Jayne C Lucke; Wayne Hall
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

Review 4.  Vascular endothelial senescence: from mechanisms to pathophysiology.

Authors:  Jorge D Erusalimsky
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

5.  Long-term Culture of EBV-induced Human Lymphoblastoid Cell Lines Reveals Chromosomal Instability.

Authors:  Marianne Volleth; Martin Zenker; Ivana Joksic; Thomas Liehr
Journal:  J Histochem Cytochem       Date:  2020-02-28       Impact factor: 2.479

6.  Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.

Authors:  Daisuke Nakano; Bai Lei; Kento Kitada; Hirofumi Hitomi; Hiroyuki Kobori; Hirohito Mori; Kazushi Deguchi; Tsutomu Masaki; Tohru Minamino; Akira Nishiyama
Journal:  Am J Hypertens       Date:  2011-11-24       Impact factor: 2.689

7.  Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-α in human proximal tubular cells.

Authors:  Kento Kitada; Daisuke Nakano; Hirofumi Hitomi; Hiroyuki Kobori; Kazushi Deguchi; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-10       Impact factor: 2.557

Review 8.  Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence.

Authors:  Yingxi Xu; Na Li; Rong Xiang; Peiqing Sun
Journal:  Trends Biochem Sci       Date:  2014-05-09       Impact factor: 13.807

9.  Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.

Authors:  Kento Kitada; Daisuke Nakano; Hiroyuki Ohsaki; Hirofumi Hitomi; Tohru Minamino; Junichi Yatabe; Robin A Felder; Hirohito Mori; Tsutomu Masaki; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Diabetes Complications       Date:  2014-06-04       Impact factor: 2.852

Review 10.  Ageing populations: the challenges ahead.

Authors:  Kaare Christensen; Gabriele Doblhammer; Roland Rau; James W Vaupel
Journal:  Lancet       Date:  2009-10-03       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.